AI assistant
Sending…
InspireMD, Inc. — Director's Dealing 2024
Jan 25, 2024
34187_dirs_2024-01-25_af4a1190-813d-4c19-a89a-79f8cd3839b6.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2024-01-23
Reporting Person: ROUBIN GARY S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2024-01-23 | Common Stock | A | 29032 | — | Acquired | 471163 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2024-01-23 | Options to purchase common stock (right to buy) | $3.14 | A | 11098 | Acquired | 2034-01-23 | Common Stock (11098) | Direct |
Footnotes
F1: These shares of common stock represent shares of restricted stock that shall vest on January 23, 2025 (the "One Year Grant Anniversary Date"), subject to the Reporting Person's continued service.
F2: The options vest and become exercisable on the One Year Grant Anniversary Date, subject to the Reporting Person's continued service.
More from InspireMD, Inc.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2
Director's Dealing
2026
Feb 2